| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |